Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Indiana University Hospital, Indianapolis

Shriners Hospital for Children, St Louis

University of California San Francisco, San Francisco

Bicetre Hospital, Le Kremlin-Bicêtre

Yale University School of Medicine, New Haven

University Medical Center Groningen, Groningen

Royal Manchester Hospital, Manchester

Birmingham Children's University, Birmingham

Great Ormond Street Hospital, London